Neuroanatomy and Pathology of Sporadic Alzheimer’s Disease

Advances in Anatomy Embryology and Cell Biology

Volumn 215, Issue , 2015, Pages

  Braak, Heiko ^a   Del Tredici, Kelly ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84918587029     PISSN: 03015556     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-319-12679-1     Document Type: Article

References (492)

1. Agnati LF, Bjelke B, Fuxe K (1995) Volume versus wiring transmission in the brain: a new theoretical frame of neuropsychopharmacology. Med Res Rev 15:33-45
2. Ahmed Z, Cooper J, Murray TK et al (2014) A novel in vivo model of tau propagation with rapid and progressive neurofibrillary tangle pathology: the pattern of spread is determined by connectivity, not proximity. Acta Neuropathol 127:667-683
3. Alafuzoff I, Pikkairainen M, Al-Sarraj S et al (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. J Neuropathol Exp Neurol 65:740-757
4. Alafuzoff I, Thal DR, Arzberger T et al (2009) Assessment of beta-amyloid deposits in human brain: a study of the BrainNet Europe Consortium. Acta Neuropathol 117:309-320
5. Albert MS, Dekosky ST, Dickson D et al (2011) The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7:270-279
6. Alheid GF (2003) Extended amygdala and basal forebrain. Ann NY Acad Sci 985:185-205
7. Alonso AC, Li B, Grundke-Iqbal I, Iqbal K (2008) Mechanism of tau-induced neurodegeneration in Alzheimer disease and related tauopathies. Curr Alzheimer Res 5:375-384
8. Alzheimer A (1906) Über einen eigenartigen schweren Erkrankungsprozeß der Hirnrinde. Neurolog Centralbl 23:1129-1136
9. Alzheimer A, Stelzmann RA, Schnitzlein HN, Murtagh R (1995) An English translation of Alzheimer’s 1907 paper, „Ü ber eine eigenartige Erkrankung der Hirnrinde“. Clin Anat 8:429-431
10. Amieva H, Le Goff M, Millet X et al (2008) Prodromal Alzheimer’s disease: successive emergence of clinical symptoms. Ann Neurol 64:492-498
11. Amunts K, Zilles K (2001) Advances in cytoarchitectonic mapping of the human cerebral cortex. Neuroimaging Clin N Am 11:151-169
12. Amunts K, Kedo O, Kindler M et al (2005) Cytoarchitectonic mapping of the human amygdala, hippocampal region and entorhinal cortex: intersubject variability and probability maps. Anat Embryol 210:343-352
13. Andreasen N, Minthon L, Vanmechelen E et al (1999) Cerebrospinal fluid tau and Abeta42 as predictors of development of Alzheimer’s disease in patients with mild cognitive impairment. Neurosci Lett 273:5-8
14. Arendt T (2000) Alzheimer’s disease as a loss of differentiation control in a subset of neurons that retain immature features in the adult brain. Neurobiol Aging 21:783-796
15. Arendt T (2004) Neurodegeneration and plasticity. Int J Dev Neurosci 22:507-514
16. Arendt T (2005) Alzheimer’s disease as a disorder of dynamic brain self-organization. Prog Brain Res 147:355-378
17. Arendt T (2012) Cell cycle activation and aneuploid neurons in Alzheimer’s disease. Mol Neurobiol 46:125-135
18. Arendt T, Brückner MK, Gertz HJ, Marcova L (1998) Cortical distribution of neurofibrillary tangles in Alzheimer’s disease matches the pattern of neurones that retain their capacity of plastic remodelling in the adult brain. Neuroscience 83:991-1002
19. Arnold SE, Hyman BT, Flory J et al (1991) The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer’s disease. Cereb Cortex 1:103-116
20. Arnold SE, Lee EB, Moberg PJ et al (2010) Olfactory epithelium amyloid-β and PHFtau pathology in Alzheimer’s disease. Ann Neurol 67:462-469
21. Arshavsky YI (2014) Alzheimer disease and cellular mechanisms of memory storage. J Neuropathol Exp Neurol 73:192-205
22. Ashford JW, Bayley PJ (2013) Retrogenesis: a model of dementia progression in Alzheimer’s disease related to neuroplasticity. J Alzheimers Dis 33:1191-1193
23. Ashford JW, Soultanian NS, Zhang SX, Geddes JW (1998) Neuropil threads are collinear with MAP2 immunostaining in neuronal dendrites of Alzheimer brain. J Neuropathol Exp Neurol 57:972-978
24. Aston-Jones C, Cohen JD (2005) An integrative theory of locus coeruleus-norepinephrine function: adaptive gain and optimal performance. Ann Rev Neurosci 28:403-450
25. Attems J, Jellinger KA (2006) Olfactory tau pathology in Alzheimer disease and mild cognitive impairment. Clin Neuropathol 25:265-271
26. Attems J, Jellinger K, Thal DR, Van Nostrand W (2011) Review: sporadic cerebral amyloid angiopathy. Neuropathol Appl Neurobiol 37:75-93
27. Attems J, Jellinger K, Thal DR (2012) The relationship between subcortical tau pathology and Alzheimer’s disease. Biochem Soc Trans 40:711-715
28. Augustinack JC, Schneider A, Mandelkow EM, Hyman BT (2002) Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer’s disease. Acta Neuropathol 103:26-35
29. Augustinack JC, Huber KE, Postelnicu GM et al (2012) Entorhinal verrucae geometry is coincident and correlates with Alzheimer’s lesions: a combined neuropathology and high-resolution ex vivo MRI analysis. Acta Neuropathol 123:85-96
30. Avila J (2006) Tau phosphorylation and aggregation in Alzheimer’s disease pathology. FEBS Lett 580:2922-2927
31. Ballatore C, Lee VMY, Trojanowski JQ (2007) Tau-mediated neurodegeneration in Alzheimer’s disease and related disorders. Nat Rev Neurosci 8:663-672
32. Bancher C, Brunner C, Lassmann H et al (1989) Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer’s disease. Brain Res 477:90-99
33. Bannister AP (2005) Inter-and intra-laminar connections of pyramidal cells in the neocortex. Neurosci Res 53:95-103
34. Barbas H (2007) Specialized elements of orbitofrontal cortex in primates. Ann NY Acad Sci 1121:10-32
35. Bartzokis G (2004) Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer’s disease. Neurobiol Aging 25:5-18
36. Barulli D, Stern Y (2013) Efficiency, capacity, compensation, maintenance, plasticity: emerging concepts in cognitive reserve. Trends Cogn Sci 17:502-509
37. Beach TG, Monsell SE, Phillips LE, Kukull W (2012a) Accuracy of the clinical diagnosis of Alzheimer’s disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010. J Neuropathol Exp Neurol 71:266-273
38. Beach TG, Sue LI, Walker DG et al (2012b) Striatal amyloid plaque density predicts Braak neurofibrillary stage and clinicopathological Alzheimer’s disease: implications for amyloid imaging. J Alzheimers Dis 28:869-876
39. Benarroch EE (1993) The central autonomic network: functional organization, dysfunction, and perspective. Mayo Clin Proc 68:988-1001
40. Benarroch EE (2009) The locus ceruleus norepinephrine system. Functional organization and potential clinical significance. Neurology 17:1699-1704
41. Benarroch EE (2013) Neocortical interneurons. Functional diversity and clinical correlations. Am Acad Neurol 81:273-280
42. Bengtsson SL, Nagy Z, Skare S et al (2005) Extensive piano practicing has regionally specific effects on white matter development. Nat Neurosci 8:1148-1150
43. Beyreuther K, Masters CL (1991) Amyloid precursor protein (APP) and beta amyloid-42 amyloid in the etiology of Alzheimer’s disease: precursor product relationships in the derangement of neuronal function. Brain Pathol 1:241-252
44. Binder LI, Guillozet-Bongaarts AL, Garcia-Sierra F, Berry RW (2004) Tau, tangles, and Alzheimer’s disease. Biochim Biophys Acta 1739:216-223
45. Blazquez-Llorca L, Garcia-Martin V, Merino-Serrais P et al (2011) Abnormal tau phosphorylation in the thorny excrescences of CA3 hippocampal neurons in patients with Alzheimer’s disease. J Alzheimer Dis 23:1-16
46. Blennow K, Hampel H (2003) Cerebrospinal fluid markers for incipient Alzheimer’s disease. Lancet Neurol 2:605-613
47. Blennow K, Zetterberg H, Minthon L et al (2007) Longitudinal stability of CSF biomarkers in Alzheimer’s disease. Neurosci Lett 419:18-22
48. Blennow K, Hampel H, Weiner M, Zetterberg H (2010) Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nat Rev Neurol 6:131-144
49. Blennow K, Zetterberg H, Fagan AM (2012) Fluid biomarkers in Alzheimer’s disease. Cold Spring Harb Perspect Med 2:a006221
50. Blessing WW (2004) Lower brain stem regulation of visceral, cardiovascular, and respiratory function. In: Paxinos G, Mai JK (eds) The human nervous system, 2nd edn. Elsevier, San Diego, pp 464-478
51. Blom ES, Giedraitis V, Zetterberg H et al (2009) Rapid progression from mild cognitive impairment to Alzheimer’s disease in subjects with elevated levels of tau in cerebrospinal fluid and the APOE epsilon4/epsilon4 genotype. Dement Geriatr Cogn Disord 27:458-464
52. Bobinski M, Wegiel J, Tarnawski M et al (1998) Duration of neurofibrillary changes in the hippocampal pyramidal neurons. Brain Res 799:156-158
53. Bohus B, Koolhaas JM, Luiten PGM et al (1996) The neurobiology of the central nuleus of the amygdala in relation to neuroendocrine and autonomic outflow. Prog Brain Res 107:447-460
54. Bonthius DJ, Solodkin A, van Hoesen GW (2005) Pathology of the insular cortex in Alzheimer disease depends on cortical architecture. J Neuropathol Exp Neurol 64:910-922
55. Bouras C, Hof P, Giannakopoulos P et al (1994) Regional distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of elderly patients: a quantitative evaluation of a one-year autopsy population from a geriatric hospital. Cereb Cortex 4:138-150
56. Braak H (1979) Spindle-shaped appendages of IIIab-pyramids filled with lipofuscin: a striking pathological change of the senescent human isocortex. Acta Neuropathol 46:197-202
57. Braak H (1980) Architectonics of the human telencephalic cortex. Springer, Berlin, pp 1-147
58. Braak H, Braak E (1990) Alzheimer’s disease: amyloid deposits and neurofibrillary changes in the striatum. J Neuropathol Exp Neurol 49:215-224
59. Braak H, Braak E (1991a) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239-259
60. Braak H, Braak E (1991b) Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections. Brain Pathol 1:213-216
61. Braak H, Braak E (1992a) The human entorhinal cortex: normal morphology and lamina-specific pathology in various diseases. Neurosci Res 15:6-31
62. Braak H, Braak E (1992b) Anatomy of the human hypothalamus (chiasmatic and tuberal region). Prog Brain Res 93:3-16
63. Braak H, Braak E (1995) Staging of Alzheimer’s disease-related neurofibrillary changes. Neurobiol Aging 16:271-284
64. Braak H, Braak E (1996) Development of Alzheimer-related neurofibrillary changes in the neocortex inversely recapitulates cortical myelogenesis. Acta Neuropathol 92:197-201
65. Braak E, Braak H (1997a) Alzheimer’s disease: transiently developing dendritic changes in pyramidal cells of sector CA1 of the Ammon’s horn. Acta Neuropathol 93:323-325
66. Braak H, Braak E (1997b) Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol Aging 18:351-357
67. Braak H, Braak E (1999) Temporal sequence of Alzheimer’s disease-related pathology. In: Peters A, Morrison JH (eds) Cerebral cortex, vol 14, Neurodegenerative and age-related changes in structure and function of the cerebral cortex. Kluwer Academic/Plenum, New York, NY, pp 475-512
68. Braak H, Del Tredici K (2004) Poor and protracted myelination as a contributory factor to neurodegenerative disorders. Neurobiol Aging 25:19-23
69. Braak H, Del Tredici K (2009) Neuroanatomy and pathology of sporadic Parkinson’s disease. Adv Anat Embryol Cell Biol 201:1-119
70. Braak H, Del Tredici K (2011) The pathological process underlying Alzheimer’s disease in individuals under thirty. Acta Neuropathol 121:171-181
71. Braak H, Del Tredici K (2012) Where, when, and in what form does sporadic Alzheimer’s disease begin? Curr Opin Neurol 25:708-714
72. Braak H, Del Tredici K (2013a) Amyloid-β may be released from non-junctional varicosities of axons generated from abnormal tau-containing brainstem nuclei in sporadic Alzheimer’s disease: a hypothesis. Acta Neuropathol 126:303-306
73. Braak H, Del Tredici K (2013b) Reply: the early pathological process in sporadic Alzheimer’s disease. Acta Neuropathol 126:615-681
74. Braak H, Del Tredici K (2014) Are cases with tau pathology occurring in the absence of the Aβ deposits part of the AD-related pathological process? Acta Neuropathol 128:767-772
75. Braak H, Braak E, Kalus P (1989a) Alzheimer’s disease: areal and laminar pathology in the occipital isocortex. Acta Neuropathol 77:494-506
76. Braak H, Braak E, Bohl J, Lang W (1989b) Alzheimer’s disease: amyloid plaques in the cerebellum. J Neurol Sci 93:277-287
77. Braak E, Braak H, Mandelkow EM (1994) A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol 87:554-567
78. Braak H, Braak E, Yilmazer D, Bohl J (1996) Functional anatomy of human hippocampal formation and related structures. J Child Neurol 11:265-275
79. Braak H, Del Tredici K, Braak E (2003) Spectrum of pathology. In: Petersen RC (ed) Mild cognitive impairment. Aging to Alzheimer’s disease. Oxford University Press, Oxford, pp 149-189
80. Braak H, Alafuzoff I, Arzberger T et al (2006a) Staging of Alzheimer’s disease-associated neurofibrillary pathology using paraffin sections and immunohistochemistry. Acta Neuropathol 112:389-404
81. Braak H, Rüb U, Schultz C, Del Tredici K (2006b) Vulnerability of cortical neurons to Alzheimer’s and Parkinson’s diseases. J Alzheimers Dis 9(3 Suppl):35-44
82. Braak H, Thal DR, Ghebremedhin E, Del Tredici K (2011) Stages of the pathological process in Alzheimer disease: age categories from 1 to 100 years. J Neuropathol Exp Neurol 70:960-969
83. Braak H, Zetterberg H, Del Tredici K, Blennow K (2013) Intraneuronal tau aggregation precedes diffuse plaque deposition, but amyloid-β changes occur before increases of tau in cerebrospinal fluid. Acta Neuropathol 126:631-641
84. Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM (2007) Forecasting the global burden of Alzheimer’s disease. Alzheimers Dement 3:186-191
85. Brunden KR, Trojanowski JQ, Lee VMY (2008) Evidence that non-fibrillar tau causes pathology linked to neurodegeneration and behavioral impairments. J Alzheimers Dis 14:393-399
86. Buchhave P, Minthon L, Zetterberg H et al (2012) Cerebrospinal fluid levels of β-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia. Arch Gen Psychiatry 69:98-106
87. Bueé L, Bussiere T, Bueé-Scherrer V et al (2000) Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res Rev 33:95-130
88. Buerger K, Ewers M, Pirttilä T et al (2006) CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer’s disease. Brain 129:3035-3041
89. Bufill E, Blesa R, August J (2013) Alzheimer’s disease: an evolutionary approach. J Anthropol Sci 91:135-157
90. Bulic B, Pickhardt M, Mandelkow EM, Mandelkow E (2010) Tau protein and tau aggregation inhibitors. Neuropharmacology 59:276-289
91. Busch C, Bohl J, Ohm TG (1997) Spatial, temporal and numeric analysis of Alzheimer changes in the nucleus coeruleus. Neurobiol Aging 18:401-406
92. Butti C, Santos M, Uppal N, Hof PR (2013) Von Economo neurons: clinical and evolutionary perspectives. Cortex 49:312-326
93. Buxbaum JD, Thinakaran G, Koliatsos V et al (1998) Alzheimer amyloid protein precursor in the rat hippocampus: transport and processing through the perforant path. J Neurosci 18:9629-9637
94. Bzdok D, Laird AR, Zilles K et al (2013) An investigation of the structural, connectional, and functional subspecialization in the human amygdala. Hum Brain Mapp 34:3247-3266
95. Campbell SK, Switzer RC, Martin TL (1987) Alzheimer’s plaques and tangles: a controlled and enhanced silver-staining method. Soc Neurosci Abstr 13:678
96. Chalermpalanupap T, Kinkead B, Hu WT et al (2013) Targeting norepinephrine in mild cognitive impairment and Alzheimer’s disease. Alzheimers Res Ther 5:21
97. Chamberlain SR, Robbins TW (2013) Noradrenergic modulation of cognition: therapeutic implications. J Psychopharmacol 8:694-718
98. Chan-Palay V, Asan E (1989) Alterations in catecholamine neurons of the locus coeruleus in senile dementia of the Alzheimer type and in Parkinson’s disease with and without dementia and depression. J Comp Neurol 287:373-392
99. Chételat G (2013) Alzheimer disease: Aβ-independent processes-rethinking preclinical AD. Nat Rev Neurol 9:123-124
100. Chételat G, FouquetM(2013) Neuroimaging biomarkers for Alzheimer’s disease in asymptomatic APOE4 carriers. Rev Neurol 169:729-736
101. Christen-Zaech S, Kraftsik R, Pillevuit O et al (2003) Early olfactory involvement in Alzheimer’s disease. Can J Neurol Sci 30:20-25
102. Chu CC, Tranel D, Damasio AR et al (1997) The autonomic-related cortex: pathology in Alzheimer’s disease. Cereb Cortex 7:86-95
103. Chui HC, Zheng L, Reed BR et al (2012) Vascular risk factors and Alzheimer’s disease: are these risk factors for plaques and tangles or for concomitant vascular pathology that increases the likelihood of dementia? An evidence-based review. Alzheimers Res Ther 4:1
104. Clavaguera F, Bolmont T, Crowther RA et al (2009) Transmission and spreading of tauopathy in transgenic mouse brain. Nat Cell Biol 11:909-913
105. Clavaguera F, Akatsu H, Fraser G et al (2013a) Brain homogenates from human tauopathies induce tau inclusions in mouse brain. Proc Natl Acad Sci USA 110:9535-9540
106. Clavaguera F, Lavenir I, Falcon B et al (2013b) “Prion-like” templated misfolding in tauopathies. Brain Pathol 23:342-349
107. Clavaguera F, Grueninger F, Tolnay M (2014) Intercellular transfer of tau aggregates and spreading of tau pathology: implications for therapeutic strategies. Neuropharmacology 76 (Pt A):9-15
108. Counts SE, Mufson EJ (2012) Locus coeruleus. In: Mai JK, Paxinos G (eds) The human nervous system, 3rd edn. Academic Press, New York, NY, pp 425-438
109. Cower CM, Mudher A (2013) Are tau aggregates toxic or protective in tauopathies? Front Neurol 4:114-126
110. Craig-Schapiro R, Fagan AM, Holtzman DM (2009) Biomarkers of Alzheimer’s disease. Neurobiol Dis 35:128-140
111. Craik FIM, Bialystok E, Freedman M (2010) Delaying the onset of Alzheimer’s disease. Bilingualism as a form of cognitive reserve. Neurology 75:1726-1729
112. Cramer SC, Chopp M (2000) Recovery recapitulates ontogeny. Trends Neurosci 23:265-271
113. Crary JF, Trojanowski JQ, Schneider JA et al (2014) Primary age-related tauopathy (PART): a common pathology associated with aging. Acta Neuropathol 128:755-766
114. Davis DG, Schmitt FA, Wekstein DR, Markesbery WR (1999) Alzheimer neuropathologic alterations in aged cognitively normal subjects. J Neuropathol Exp Neurol 58:376-388
115. de Calignon A, Polydoro M, Suarez-Calvet M et al (2012) Propagation of tau pathology in a model of early Alzheimer’s disease. Neuron 73:685-697
116. de la Monte SM, Tong M (2013) Brain metabolic dysfunction at the core of Alzheimer’s disease. Biochem Pharmacol 88:548-559
117. de Silva R, Lashley T, Gibb G et al (2003) Pathological inclusion bodies in tauopathies contain distinct complements of tau with three or four microtubule-binding repeat domains as demonstrated by new specific monoclonal antibodies. Neuropathol Appl Neurobiol 29:288-302
118. DeFelipe J, Alonso-Nanclares L, Arellano JI (2002) Microstructure of the neocortex: comparative aspects. J Neurocytol 31:299-316
119. Del Tredici K, Braak H (2012) Spinal cord lesions in sporadic Parkinson’s disease. Acta Neuropathol 124:643-664
120. Del Tredici K, Hawkes CH, Ghebremedhin E, Braak H (2010) Lewy pathology in the submandibular gland of individuals with incidental Lewy body disease and sporadic Parkinson’s disease. Acta Neuropathol 119:703-713
121. Delacourte A (2008) Tau pathology and neurodegeneration: an obvious but misunderstood link. J Alzheimers Dis 14:437-440
122. Delacourte A, David JP, Sergeant N et al (1999) The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer’s disease. Neurology 52:1158-1165
123. Delbeuck X, van der Linden M, Collette F (2003) Alzheimer’s disease as a disconnection syndrome? Neuropsychol Rev 13:79-92
124. DeLong MR, Wichmann T (2007) Circuits and circuit disorders of the basal ganglia. Arch Neurol 64:20-24
125. Dickerson BC, Stoub TR, Shah RC et al (2011) Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adults. Neurology 76:1395-1402
126. Dickson DW (1997a) The value of cross-sectional neuroanatomical studies as a conceptual framework for prospective clinicopathological studies. Neurobiol Aging 18:382-386
127. Dickson DW (1997b) The pathogenesis of senile plaques. J Neuropathol Exp Neurol 56:321-339
128. Dickson DW, Vickers JC (2001) The morphological phenotype of beta-amyloid plaques and associated neuritic changes in Alzheimer’s disease. Neuroscience 105:99-107
129. Dickson DW, Rademakers R, Hutton ML (2007) Progressive supranuclear palsy: pathology and genetics. Brain Pathol 17:74-82
130. Ding H, Johnson GV (2008) The last tangle of tau. J Alzheimers Dis 14:441-447
131. Ding SL, van Hoesen GW (2010) Borders, extent, and topography of human perirhinal cortex as revealed using multiple modern neuroanatomical and pathological markers. Hum Brain Mapp 31:1359-1379
132. Dolan D, Troncoso J, Resnick SM et al (2010) Age, Alzheimer’s disease and dementia in the Baltimore longitudinal study of ageing. Brain 133:2225-2231
133. Dong S, Duan Y, Hu Y, Zhao Z (2012) Advances in the pathogenesis of Alzheimer’s disease: a re-evaluation of amyloid cascade hypothesis. Transl Neurodegener 1:1-18
134. Doody RS, Thomas RG, Farlow M et al (2014) Phase 3 trials of solanezumab for mild-to-moderate Alzheimer’s disease. N Engl J Med 370:311-321
135. Double KL, Dedov VN, Fedorow H et al (2008) The comparative biology of neuromelanin and lipofuscin in the human brain. Cell Mol Life Sci 11:1669-1682
136. Draganski B, May A (2008) Training-induced structural changes in the adult human brain. Behav Brain Res 192:137-142
137. Dringenberg HC (2000) Alzheimer’s disease: more than a ‘cholinergic disorder’-evidence that cholinergic-monoaminergic interactions contribute to EEG slowing and dementia. Behav Brain Res 115:236-249
138. Dubois B, Feldman HH, Jacova C et al (2010) Revising the definition of Alzheimer’s disease: a new lexicon. Lancet Neurol 9:1118-1127
139. Dugger BN, Tu M, Murray ME, Dickson DW (2011) Disease specificity and pathologic progression of tau pathology in brainstem nuclei of Alzheimer’s disease and progressive supranuclear palsy. Neurosci Lett 491:122-126
140. Dugger BN, Hidalgo JA, Chiarolanza G et al (2013) The distribution of phosphorylated tau in spinal cords of Alzheimer’s disease and non-demented individuals. J Alzheimer Dis 34:529-536
141. Dujardin S, Lécolle K, Caillierez R, Bégard S et al (2014) Neuron-to-neuron wild-type tau protein transfer through a trans-synaptic mechanism: relevance to sporadic tauopathies. Acta Neuropathol Commun 2:14
142. Duyckaerts C (2011) Tau pathology in children and young adults: can you still be unconditionally baptist? Acta Neuropathol 121:145-147
143. Duyckaerts C (2013) Neurodegenerative lesions: seeding and spreading. Rev Neurol 169:825-833
144. Duyckaerts C, Hauw JJ (1997) Prevalence, incidence and duration of Braak’s stages in the general population: can we know? Neurobiol Aging 18:362-369
145. Duyckaerts C, Delatour B, Potier MC (2009) Classification and basic pathology of Alzheimer’s disease. Acta Neuropathol 118:5-36
146. Elfenbein HA, Rosen RF, Stephens SL et al (2007) Cerebral beta-amyloid angiopathy in aged squirrel monkeys. Histol Histopathol 22:155-167
147. Elobeid A, Soininen H, Alafuzoff I (2011) Hyperphosphorylated tau in young and middle-aged subjects. Acta Neuropathol 123:97-104
148. Englund H, Degerman Gunnarsson M, Brundin RM et al (2009) Oligomerization partially explains the lowering of Aβ42 in Alzheimer’s disease cerebrospinal fluid. Neurodegener Dis 6:139-147
149. Erickson KI, Weinstein AM, Lopez OL (2012) Physical activity, brain plasticity, and Alzheimer’s disease. Arch Med Res 43:615-621 Espan˜a RA, Berridge CW (2006) Organization of noradrenergic efferents to arousal-related basal forebrain. J Comp Neurol 496:668-683
150. Ewers M, Frisoni GB, Teipel SJ et al (2011) Staging Alzheimer’s disease progression with multimodality neuroimaging. Prog Neurobiol 95:535-546
151. Ewers M, Walsh C, Trojanowski JQ et al (2012) Prediction of conversion from mild cognitive imairment to Alzheimer’s disease dementia based upon biomarkers and neuropsychological test performance. Neurobiol Aging 33:1203-1214
152. Fagan AM, Mintun MA, Shah AR et al (2009) Cerebrospinal fluid tau and ptau(181) increase with cortical amyloid deposition in cognitively normal individuals: implications for future clinical trials of Alzheimer’s disease. EMBO Mol Med 1:371-380
153. Farkas E, Luiten PGM (2001) Cerebral microvascular pathology in aging and Alzheimer’s disease. Prog Neurobiol 64:575-611
154. Feldengut S, Del Tredici K, Braak H (2013) Paraffin sections of 70-100 μm: a novel technique and its benefits for studying the nervous system. J Neurosci Method 215:241-244
155. Femminella GD, Rengo G, Komici K et al (2014) Autonomic dysfunction in Alzheimer’s disease: tools for assessment and review of the literature. J Alzheimers Dis 42:369-377
156. Ferrer I (2012) Defining Alzheimer as a common age-related neurodegenerative process not inevitably leading to dementia. Prog Neurobiol 97:38-51
157. Fiala JC (2007) Mechanisms of amyloid plaque pathogenesis. Acta Neuropathol 114:551-571
158. Fields RD (2011) Imaging learning: the search for a memory trace. Neuroscientist 17:185-196
159. Fodero-Tavoletti MT, Okamura N, Furumoto S et al (2011) 18F-THK523: a novel in vivo tau imaging ligand for Alzheimer’s disease. Brain 134:1089-1100
160. Fodero-Tavoletti MT, Furumoto S, Taylor L et al (2014) Assessing THK523 selectivity for tau deposits in Alzheimer’s disease and non-Alzheimer’s disease tauopathies. Alzheimers Res Ther 6:11-21
161. Fotuhi M, Hachinski V, Whitehouse PJ (2009) Changing perspectives regarding late-life dementia. Nat Rev Neurol 5:649-658
162. Frackowiac J, Zoltowska A, Wisniewski HM (1994) Non-fibrillar beta-amyloid protein is associated with smooth muscle cells of vessel walls in Alzheimer disease. J Neuropathol Exp Neurol 53:637-645
163. Frankfort SV, Tulner LR, van Campen JP et al (2008) Amyloid beta protein and tau in cerebrospinal fluid and plasma as biomarkers for dementia: a review of recent literature. Curr Clin Pharmacol 3:123-131
164. Franssen EH, Kluger A, Torossian CL, Reisberg B (1993) The neurologic syndrome of severe Alzheimer’s disease. Relationship to functional decline. Arch Neurol 50:1029-1039
165. Freedman M, Alladi S, Chertkow H et al (2014) Delaying onset of dementia: are two languages enough? Behav Neurol 2014, 808137
166. Friedman JI, Adler DH, Davis KL (1999) The role of norepinephrine in the pathophysiology of cognitive disorders: potential applications to the treatment of cognitive dysfunction in Schizophrenia and Alzheimer’s disease. Biol Psychiatry 46:1243-1252
167. Frost B, Diamond MI (2010) Prion-like mechanisms in neurodegenerative diseases. Nat Rev Neurosci 11:155-159
168. Gallyas F (1971) Silver staining of Alzheimer’s neurofibrillary changes by means of physical development. Acta Morphol Acad Sci Hung 19:1-8
169. Garcia-Sierra F, Ghoshal N, Quinn B et al (2003) Conformational changes and truncation of tau protein during tangle evolution in Alzheimer’s disease. J Alzheimer’s disease 5:65-77
170. Gärtner H, Minnerop M, Pieperhoff P et al (2013) Brain morphometry shows effects of long-term musical practice in middle-aged keyboard players. Front Psychol 4:636
171. Gates GA, Beiser A, Rees TS et al (2002) Central auditory dysfunction may precede the onset of clinical dementia in people with probable Alzheimer’s disease. J Am Geriatr Soc 50:74-82
172. German DC, White CL, Sparkman DR (1987) Alzheimer’s disease: neurofibrillary tangles in nuclei that project to the cerebral cortex. Neuroscience 21:305-312
173. German DC, Manaye KF, White CL III et al (1992) Disease-specific patterns of locus coeruleus cell loss. Ann Neurol 32:667-676
174. Geula C, Mesulam MM (2012) Brainstem cholinergic systems. In: Mai JK, Paxinos G (eds) The human nervous system, 3rd edn. Academic Press, New York, NY, pp 471-547
175. Ghebremedhin E, Schultz C, Braak E, Braak H (1998) High frequency of apolipoprotein E epsilon4 allele in young individuals with very mild Alzheimer’s disease-related neurofibrillary changes. Exp Neurol 153:152-155
176. Giacobini E, Gold G (2013) Alzheimer disease therapy-moving from amyloid-β to tau. Nat Rev Neurol 9:677-686
177. Giannakopoulos P, Hof PR, Mottier S et al (1994) Neuropathological changes in the cerebral cortex of 1258 cases from a geriatric hospital: retrospective clinicopathological evaluation of a 10-year autopsy population. Acta Neuropathol 87:456-468
178. Giannakopoulos P, Herrmann FR, Nussie`re T et al (2003) Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer’s disease. Neurology 60:1495-1500
179. Gloor P (1997) The temporal lobe and limbic system. Oxford University Press, New York, NY, pp 1-865
180. Goedert M, Spillantini MG (2006) A century of Alzheimer’s disease. Science 314:777-781
181. Goedert M, Spillantini MG, Cairns NJ, Crowther RA (1992) Tau proteins from Alzheimer paired helical filaments: abnormal phosphorylation of all six isoforms. Neuron 8:159-168
182. Goedert M, Trojanowski JQ, Lee VMY (1997) The neurofibrillary pathology of Alzheimer’s disease. In: Rosenberg RN (ed) The molecular and genetic basis of neurological disease, 2nd edn. Butterworth-Heinemann, Boston, MA, pp 613-627
183. Goedert M, Klug A, Crowther RA (2006) Tau protein, the paired helical filament and Alzheimer’s disease. J Alzheimers Dis 9(Suppl):195-207
184. Goedert M, Clavaguera F, Tolnay M (2010) The propagation of prion-like protein inclusions in neurodegenerative diseases. Trends Neurosci 33:317-325
185. Goedert M, Falcon B, Clavaguera F et al (2014) Prion-like mechanisms in the pathogenesis of tauopathies and synucleinopathies. Curr Neurol Neurosci Rep 14:495
186. Gogtay N, Thompson PM (2010) Mapping gray matter development: implications for typical development and vulnerability to psychopathology. Brain Cogn 72:6-15
187. Gold G, Bouras C, Kövari E et al (2000) Clinical validity of Braak neuropathological staging in the oldest-old. Acta Neuropathol 99:579-582
188. Golde TE, Schneider LS, Koo EH (2011) Anti-aβ therapeutics in Alzheimer’s disease: the need for a paradigm shift. Neuron 69:203-213
189. Gong CX, Grundke-Iqbal I, Iqbal K (2010) Targeting tau protein in Alzheimer’s disease. Drugs Aging 27:351-365
190. Grantham C, Geerts H (2002) The rationale behind cholinergic drug treatment for dementia related to cerebrovascular disease. J Neurol Sci 203-204:131-136
191. Grimmer T, Henriksen G, Wester HJ et al (2009) Clinical severity of Alzheimer’s disease is associated with PiB uptake in PET. Neurobiol Aging 30:1902-1909
192. Grinberg LT, Thal DR (2010) Vascular pathology in the aged human brain. Acta Neuropathol 119:277-290
193. Grinberg LT, Rüb U, Ferretti REL et al (2009) The dorsal raphe nucleus shows phospho-tau neurofibrillary changes before the transentorhinal region in Alzheimer’s disease. A precocious onset? Neuropathol Appl Neurobiol 35:406-416
194. Grinberg LT, Korczyn AD, Heinsen H (2012) Cerebral amyloid angiopathy impact on endothelium. Exp Gerontol 47:838-842
195. Grober E, Dickson D, Sliwinski MJ et al (1999) Memory and mental status correlates of modified Braak staging. Neurobiol Aging 20:573-579
196. Groenewegen HJ, Trimble M (2007) The ventral striatum as an interface between the limbic and motor systems. CNS Spectr 12:887-892
197. Grudzien A, Shaw P, Weintraub S et al (2007) Locus coeruleus neurofibrillary degeneration in aging, mild cognitive impairment and early Alzheimer’s disease. Neurobiol Aging 28:327-335
198. Grundke-Iqbal I, Iqbal K, Tung YC et al (1986) Abnormal phosphorylation of the microtubuleassociated protein τ (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci USA 83:4913-4917
199. Guo JL, Lee VMY (2011) Seeding of normal tau by pathological tau conformers drives pathogenesis of Alzheimer-like tangles. J Biol Chem 286:15317-15331
200. Guo JL, Lee VMY (2014) Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases. Nat Med 20:1-9
201. Haass C, Selkoe DJ (2007) Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer’s amyloid β-peptide. Nat Rev Mol Cell Biol 8:101-112
202. Haass C, Kaether C, Thinakaran G, Sisodia S (2012) Trafficking and proteolytic processing of APP. Cold Spring Harb Perspect Med 2:a006270
203. Haber SN, Gdowski MJ (2004) The basal ganglia. In: Paxinos G, Mai JK (eds) The human nervous system, 2nd edn. Elsevier, San Diego, CA, pp 677-738
204. Haglund M, Sjöbeck M, Englund E (2006) Locus ceruleus degeneration is ubiquitous in Alzheimer’s disease: possible implications for diagnosis and treatment. Neuropathology 26:528-532
205. Hall GF, Saman S (2012) Death or secretion? The demise of a plausible assumption about CSF-tau in Alzheimer disease? Commun Integr Biol 5:1-4
206. Halliday GM, Leverenz JB, Schneider JS, Adler CH (2014) The neurobiological basis of cognitive impairment in Parkinson’s disease. Mov Disord 29:634-650
207. Hamel E (2006) Perivascular nerves and the regulation of cerebrovascular tone. J Appl Physiol 100:1059-1064
208. Hampel H, Frank R, Broich K et al (2010) Biomarkers for Alzheimer’s disease: academic, industry and regulatory perspectives. Nat Rev Drug Discov 9:560-574
209. Hanke J (1997) Sulcal pattern of the anterior parahippocampal gyrus in the human adult. Ann Anat 179:335-339
210. Hardy JA (2006) Alzheimer’s disease: the amyloid cascade hypothesis: an update and reappraisal. J Alzheimers Dis 9:151-153
211. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 297:353-356
212. Harris JA, Devidze N, Verret L et al (2010) Transsynaptic progression of amyloid-β-induced neuronal dysfunction within entorhinal-hippocampal network. Neuron 68:428-441
213. Heimer L, van Hoesen GW (2006) The limbic lobe and its output channels: implications for emotional functions and adaptive behavior. Neurosci Biobehav Rev 30:126-147
214. Heimer L, de Olmos J, Alheid GF, Záborszky L (1991) “Perestroika” in the basal forebrain: opening the border between neurology and psychiatry. Prog Brain Res 87:109-165
215. Hertz L (1989) Is Alzheimer’s disease an anterograde degeneration, originating in the brainstem, and disrupting metabolic interactions between neurons and glial cells? Brain Res Rev 14:335-353
216. Higuchi M, Lee MY, Trojanowski JQ (2002) Tau and axonopathy in neurodegenerative disorders. NeuroMol Med 2:131-150
217. Hof PR, Bussiere T, Gold G et al (2003) Stereologic evidence for persistence of viable neurons in layer II of the entorhinal cortex and the CA1 field in Alzheimer disease. J Neuropathol Exp Neurol 62:55-67
218. Holmes BB, Furman JL, Mahan TE et al (2014) Proteopathic tau seeding predicts tauopathy in vivo. Proc Natl Acad Sci USA 111:E4376-4385
219. Holstege G, Mouton LJ, Gerrits NM (2004) Emotional motor system. In: Paxinos G, Mai JK (eds) The human nervous system, 2nd edn. Elsevier, San Diego, CA, pp 1306-1325
220. Howard A, Tamas G, Soltesz I (2005) Lighting the chandelier: new vistas for axo-axonic cells. Trends Neurosci 28:310-316
221. Hunter JM, Kwan J, Malek-Ahmadi M et al (2012) Morphological and pathological evolution of the brain microcirculation in aging and Alzheimer’s disease. PLoS One 7:e36893
222. Hyman BT, G_omez-Isla T (1994) Alzheimer’s disease is a laminar, regional, and neural system specific disease, not a global brain disease. Neurobiol Aging 15:353-354
223. Hyman BT, G_omez-Isla T (1997) The natural history of Alzheimer neurofibrillary tangles and amyloid deposits. Neurobiol Aging 18:386-387
224. Hyman BT, Trojanowski JQ (1997) Editorial on consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease. J Neuropathol Exp Neurol 56:1095-1097
225. Hyman BT, Kromer LJ, van Hoesen GW (1988) A direct demonstration of the perforant pathway terminal zone in Alzheimer’s disease using the monoclonal antibody Alz-50. Brain Res 450:392-397
226. Hyman BT, van Hoesen GW, Damasio AR (1990) Memory-related systems in Alzheimer’s disease: an anatomic study. Neurology 40:1721-1730
227. Hyman BT, Marzloff K, Arrigada PV (1993) The lack of accumulation of senile plaques or amyloid burden in Alzheimer’s disease suggests a dynamic balance between amyloid deposition and resolution. J Neuropathol Exp Neurol 52:594-600
228. Iadecola C (2004) Neurovascular regulation in the normal brain and in Alzheimer’s disease. Nat Rev Neurosci 5:347-360
229. Iadecola C (2010) The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia. Acta Neuropathol 120:287-296
230. Iba M, Guo JL, McBride JD et al (2013) Synthetic tau fibrils mediate transmission of neurofibrillary tangles in a transgenic mouse model of Alzheimer-like tauopathy. J Neurosci 33: 1024-1037
231. Ikonomovic MD, Klunk WE, Abrahamson EE et al (2008) Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer’s disease. Brain 131:1630-1645
232. Insausti R, Amaral DG (2012) Hippocampal formation. In: Mai JK, Paxinos G (eds) The human nervous system, 3rd edn. Academic Press, San Diego, CA, pp 896-942
233. Iqbal K, Grundke-Iqbal I (2008) Alzheimer neurofibrillary degeneration: significance, etiopathogenesis, therapeutics and prevention. J Cell Mol Med 12:38-55
234. Iqbal K, Grundke-Iqbal I (2011) Opportunities and challenges in developing Alzheimer disease therapeutics. Acta Neuropathol 122:543-549
235. Iqbal K, Liu F, Gong CX et al (2009) Mechanisms of tau-induced neurodegeneration. Acta Neuropathol 118:53-69
236. Iseki E, Tsunoda S, Suzuki K et al (2002) Regional quantitative analysis of NFT in brains of non-demented elderly persons: comparisons with findings in brains of late-onset Alzheimer’s disease and limbic NFT dementia. Neuropathology 22:34-39
237. Issidorides MR, Mytilineou C, Panayotacopoulou T, Yahr MD (1991) Lewy bodies in parkinsonism share components with intraneuronal protein bodies of normal brains. J Neural Transm 3:49-61
238. Ittner A, Ke JD, van Eersel J et al (2011) Brief update on different roles of tau in neurodegeneration. IUBMB Life 63:495-502
239. Jack CR Jr (2012) Alzheimer disease: new concepts on its neurobiology and the clinical role imaging will play. Radiology 263:344-361
240. Jack CR Jr, Holtzman DM (2013) Biomarker modelling of Alzheimer’s disease. Neuron 80:1347-1358
241. Jack CR Jr, Knopman DS, Jagust WJ et al (2013) Tracking pathophysiological processes in Alzheimer’s disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol 12:207-216
242. Jagust WJ, Landau SM, Alzheimer’s Disease Neuroimaging Initiative (2012) Apolipoprotein E, not fibrillary β-amyloid, reduces cerebral glucose metabolism in normal aging. J Neurosci 32:18227-18233
243. Jellinger KA, Attems J (2007) Neurofibrillary tangle-predominant dementia: comparison with classical Alzheimer disease. Acta Neuropathol 113:107-117
244. Jensen JR, Cisek K, Funk KE et al (2011) Research towards tau imaging. J Alzheimers Dis 26 (Suppl 3):147-157
245. Johnson SB, Blum RW, Giedd JN (2009) Adolescent maturity and the brain: the promise and pitfalls of neuroscience research in adolescent health policy. J Adolesc Health 45:216-221
246. Jucker M, Walker LC (2011) Pathogenic protein seeding in Alzheimer’s disease and other neurodegenerative disorders. Ann Neurol 70:532-540
247. Kalaria RN, Stockmeier CA, Harik SI (1989) Brain microvessels are innervated by locus ceruleus noradrenergic neurons. Neurosci Lett 97:203-208
248. Kalus P, Braak H, Braak BJ (1989) The presubicular region in Alzheimer’s disease: topography of amyloid deposits and neurofibrillary changes. Brain Res 494:198-203
249. Karran E, Mercken M, de Strooper B (2011) The amyloid cascade hypothesis for Alzheimer’s disease: an appraisal for the development of therapeutics. Nat Rev Drug Discov 10:698-712
250. Kaufman SK, Diamond MI (2013) Prion-like propagation of protein aggregation and related therapeutic strategies. Neurotherapeutics 10:371-382
251. Kemper TL (1984) Neuroanatomical and neuropathological changes in normal aging and in dementia. In: Albert ML (ed) Clinical neurology of aging. Oxford University Press, New York, NY, pp 9-52
252. Kepe V, Moghbei MC, Långström B et al (2013) Amyloid-β positron emission tomography imaging probes: a critical review. J Alzheimers Dis 36:613-631
253. Kitt CA, Price DL, Struble RG et al (1985a) Evidence for cholinergic neurites in senile plaques. Science 226:1443-1445
254. Kitt CA, Struble RG, Cork LC et al (1985b) Catecholaminergic neurites in senile plaques in prefrontal cortex of aged nonhuman primates. Neuroscience 16:691-699
255. Klunk WE, Engler H, Nordberg A et al (2004) Imaging brain amyloid in Alzheimer’s disease with Pittsburgh Compound-B. Ann Neurol 55:306-319
256. Kolarova M, Garcia-Sierra F, Bartos A et al (2012) Structure and pathology of tau protein in Alzheimer disease. Int J Alzheimer Dis 2012, 731526
257. Koo EH, Sisodia SS, Archer DR et al (1990) Precursor of amyloid protein in Alzheimer disease undergoes fast axonal transport. Proc Natl Acad Sci USA 87:1561-1565
258. Kopeikina KJ, Hyman BT, Spires-Jones TL (2012) Soluble forms of tau are toxic in Alzheimer’s disease. Transl Neurosci 3:223-233
259. Köpke E, Tung YC, Shaikh S et al (1993) Microtubule-associated protein tau-abnormal phosphorylation of a non-paired helical filament pool in Alzheimer’s disease. J Biol Chem 268:24374-24384
260. Korczyn AD (2008) The amyloid cascade hypothesis. Alzheimers Dement 4:176-178
261. Korczyn AD (2013) Is Alzheimer’s disease a homogeneous disease entity? J Neural Transm 120:1475-1477
262. Korczyn AD, Vakhapova V, Grinberg LT (2012) Vascular dementia. J Neurol Sci 322:2-10
263. Kovacech B, Skrabana R, NovakM(2010) Transition of tau protein from disordered to misordered in Alzheimer’s disease. Neurodegener Dis 7:24-27
264. Kovács T (2013) The olfactory system in Alzheimer’s disease: pathology, pathophysiology, and pathway for therapy. Transl Neurosci 4:34-45
265. Kovács T, Cairns NJ, Lantos PL (1999) β-amyloid deposition and neurofibrillary tangle formation in the olfactory bulb in ageing and Alzheimer’s disease. Neuropathol Appl Neurobiol 25:481-491
266. Kovács T, Milenkovic I, Wöhrer A et al (2013) Non-Alzheimer neurodegenerative pathologies and their combinations are more frequent than commonly believed in the elderly brain: a community-based autopsy series. Acta Neuropathol 126:365-384
267. Kuchibhotla KV, Wegmann S, Kopeikina KJ et al (2014) Neurofibrillary tangle-bearing neurons are functionally integrated in cortical circuit in vivo. Proc Natl Acad Sci USA 111:510-514
268. Kurylo DD, Corkin S, Allard T et al (1993) Auditory function in Alzheimer’s disease. Neurology 43:1893-1899
269. Lasagna-Reeves C, Castillo-Carranza D, Sengupta U et al (2012) Identification of oligomers at early stages of tau aggregation in Alzheimer’s disease. FASEB J 26:1946-1959
270. Lazarov O, Morfini GA, Lee EB et al (2005) Axonal transport, amyloid precursor protein, kinesin-1, and the processing apparatus: revisited. J Neurosci 25:2386-2395
271. Lee VM-Y, Goedert M, Trojanowski JQ (2001) Neurodegeneration and tauopathies. Annu Rev Neurol 24:1121-1159
272. Lee SJ, Desplats P, Sigurdson C et al (2010) Cell-to-cell transmission of non-prion protein aggregates. Nat Rev Neurol 6:702-706
273. Lee S, Kim W, Li Z, Hall FG (2012a) Accumulation of vesicle-associated human tau in distal dendrites drives degeneration and tau secretion in an in situ cellular tauopathy model. Int J Alzheimers Dis 2012, 172837
274. Lee Y, Morrison BM, Li Y, Lengacher S et al (2012b) Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature 487:443-448
275. Li B, Chohan MO, Grundke-Iqbal I, Iqbal K (2007) Disruption of microtubule network by Alzheimer abnormally hyperphosphorylated tau. Acta Neuropathol 113:501-511
276. Liberati G, Raffone A, Belardinelli O (2012) Cognitive reserve and its implications for rehabilitation and Alzheimer’s disease. Cogn Process 13:1-12
277. Linn RT, Wolf PA, Bachman DL et al (1995) The ‘preclinical phase’ of probably Alzheimer’s disease. A 13-year prospective study of the Framingham cohort. Arch Neurol 52:485-490
278. Liu L, Drouet V, Wu JW et al (2012) Trans-synaptic spread of tau pathology in vivo. PLoS One 7: e31302
279. Lou K, Yao Y, Hoye AT, James MJ et al (2014) Brain-penetrant, orally bioavailable microtubulestabilizing small molecules are potential candidate therapeutics for Alzheimer’s disease and related tauopathies. J Med Chem 57:6116-6127
280. Love S, Chalmers K, Ince P et al (2014) Development, appraisal, validation and implementation of a consensus protocol for the assessment of cerebral amyloid angiopathy in post-mortem brain tissue. Am J Neurodegener Dis 3:19-32
281. Maarouf CL, Daugs ID, Kokjohn TA et al (2010) The biochemical aftermath of anti-amyloid immunotherapy. Mol Neurodegener 5:39-54
282. Mackic JB, Bading J, Ghiso J et al (2002) Circulating amyloid-beta peptide crosses the blood-brain barrier in aged monkeys and contributes to Alzheimer’s disease lesions. Vascul Pharmacol 38:303-313
283. Maeda S, Sahara N, Saito Y et al (2007) Granular tau oligomers as intermediates of tau filaments. Biochemistry 46:3856-3861
284. Mandelkow EM, Mandelkow E (1998) Tau in Alzheimer’s disease. Trends Cell Biol 8:425-427
285. Mandelkow EM, Mandelkow E (2012) Biochemistry and cell biology of tau protein in neurofibrillary degeneration. Cold Spring Harb Perspect Med 2:a006247
286. Mandelkow E, von Bergen M, Biernat J, Mandelkow EM (2007) Structural principles of tau and the paired helical filaments of Alzheimer’s disease. Brain Pathol 17:83-90
287. Mann DM (1983) The locus coeruleus and its possible role in ageing and degenerative disease of the human central nervous system. Mech Ageing Dev 23:73-94
288. Mann DMA, Hardy J (2013) Amyloid or tau-the chicken or the egg? Acta Neuropathol 126:609-613
289. Mann DMA, Yates PO, Hawkes J (1982) The noradrenergic system in Alzheimer and multi-infarct dementias. J Neurol Neurosurg Psychiatry 45:113-119
290. Marien MR, Colpaert FC, Rosenquist AC (2004) Noradrenergic mechanisms in neurodegenerative diseases: a theory. Brain Res Brains Res Rev 45:38-78
291. Markesbery WR, Schmitt FA, Kryscio RJ et al (2006) Neuropathologic substrate of mild cognitive impairment. Arch Neurol 63:38-46
292. Maruyama M, Shimada H, Suhara T et al (2013) Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls. Neuron 79:1-15
293. Masliah E, Alford M, Adame A et al (2003) Abeta1-42 promotes cholinergic sprouting in patients with AD and Lewy body variant of AD. Neurology 61:206-211
294. Masters CL, Beyreuther K (2006) Pathways to the discovery of the neuronal origin and proteolytic biogenesis of Aβ amyloid of Alzheimer’s disease. In: Jucker M, Beyreuther K, Haass C, Nitsch R, Christen Y (eds) Alzheimer: 100 years and beyond. Springer, Berlin, pp 143-149
295. Masters CL, Selkoe DJ (2012) Biochemistry of amyloid β-protein and amyloid deposits in Alzheimer’s disease. Cold Spring Harb Perspect Med 2:a006262
296. Mattson MP (2004) Pathways towards and away from Alzheimer’s disease. Nature 430:631-639
297. Mattsson N, Zetterberg H, Hansson O et al (2009) CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. JAMA 302:385-393
298. Mattsson N, Portelius E, Rolstad S et al (2012) Longitudinal cerebrospinal fluid biomarkers over four years in mild cognitive impairment. J Alzheimers Dis 30:767-778
299. Mayeux R (2010) Early Alzheimer’s disease. N Engl J Med 362:2194-2201
300. Mayeux R, Stern Y (2012) Epidemiology of Alzheimer’s disease. Cold Spring Harb Perspect Med 2:a006239
301. Medina M, Avila J (2014a) The role of extracellular tau in the spreading of neurofibrillary pathology. Front Cell Neurosci 8:113
302. Medina M, A ´ vila J (2014b) New perspectives on the role of tau in Alzheimer’s disease. Implication for therapy. Biochem Pharmacol 88:540-547
303. Meel-van den Abeelen AS, Lagro J et al (2013) Baroreflex function is reduced in Alzheimer’s disease: a candidate biomarker? Neurobiol Aging 34:1170-1176
304. Meng X, D’Arcy C (2012) Education and dementia in the context of the cognitive reserve hypothesis: a systematic review with meta-analyses and quantitative analyses. PLoS One 7: e38268
305. Mercken M, Vandermeeren M, Lübke U et al (1992) Monoclonal antibodies with selective specifity for Alzheimer tau are directed against phosphatase-sensitive epitopes. Acta Neuropathol 84:265-272
306. Merino-Serrais P, Benavides-Piccione R, Blazquez-Llorca L et al (2013) The influence of phospho-tau on dendritic spines of cortical pyramidal neurons in patients with Alzheimer’s disease. Brain 136:1913-1928
307. Mesulam MM (1998) From sensation to cognition. Brain 121:1013-1052
308. Mesulam MM (2004) The cholinergic innervation of the human cerebral cortex. Prog Brain Res 145:67-78
309. Mesulam MM, Mufson EJ (1993) The insula of Reil in man and monkey. In: Jones EG, Peters A (eds) Cerebral cortex. Association and auditory cortices, vol 4. Plenum, New York, NY, pp 179-225
310. Mesulam MM, Shaw P, Mash D, Weintraub S (2004) Cholinergic nucleus basalis tauopathy emerges early in the aging-MCI-AD continuum. Ann Neurol 55:815-828
311. Mesulam MM, Weintraub S, Rogalski EJ et al (2014) Asymmetry and heterogeneity of Alzheimer’s and frontotemporal pathology in primary progressive aphasia. Brain 137:1176-1192
312. Mirra S, Heyman A, McKeel D et al (1991) The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer’s disease. Neurology 41:479-486
313. Moceri VM, Kukull WA, Emanuel I et al (2000) Early-life risk factors and the development of Alzheimer’s disease. Neurology 54:415-420
314. Molnar FJ, Man-Son-Hing M, Fergusson D (2009) Systematic review of measures of clinical significance employed in randomized controlled trials of drugs for dementia. J Am Geriatr Soc 57:536-546
315. Montine TJ, Phelps CH, Beach TG et al (2012) National Institute on Aging-Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach. Acta Neuropathol 123:1-11
316. Morawski M, Brückner G, Jäger C et al (2010) Neurons associated with aggrecan-based perineuronal nets are protected against tau pathology in subcortical regions in Alzheimer’s disease. Neuroscience 169:1347-1363
317. Morris JC, Storandt M, Miller JP et al (2001) Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol 58:397-405
318. Morris JC, Blennow K, Froelich L et al (2014) Harmonized diagnostic criteria for Alzheimer’s disease: recommendations. J Intern Med 275:204-210
319. Morrison JH, Hof PR (1997) Life and death of neurons in the aging brain. Science 278:412-419
320. Morrison JH, Foote SL, O’Connor D, Bloom FE (1982) Laminar, tangential and regional organization of the nordrenergic innervation of monkey cortex: dopamin-β-hydroxylase immunohistochemistry. Brain Res Bull 9:309-319
321. Morsch R, Simon W, Coleman PD (1999) Neurons may live for decades with neurofibrillary tangles. J Neuropathol Exp Neurol 58:188-197
322. Mount C, Downton C (2006) Alzheimer disease: progress or profit? Nat Med 12:780-784
323. Mucke L, Selkoe DJ (2012) Neurotoxicity of amyloid β-protein: synaptic and network dysfunction. Cold Spring Harb Perspect Med 2:a006338
324. Mufson EJ, Chen EY, Cochran EJ et al (1999) Entorhinal cortex β-amyloid load in individuals with mild cognitive imüairment. Exp Neurol 158:469-490
325. Mufson EJ, Binder L, Counts SE et al (2012) Mild cognitive impairment: pathology and mechanisms. Acta Neuropathol 123:13-30
326. Mufson EJ, Ward S, Binder L (2013) Prefibrillar tau oligomers in mild cognitive impairment and Alzheimer’s disease. Neurodegener Dis 13:151-153
327. Munoz DG, Wang D (1992) Tangle-associated neuritic clusters. A new lesion in Alzheimer’s disease and aging suggests that aggregates of dystrophic neurites are not necessarily associated with beta/A4. Am J Pathol 140:1167-1178
328. Muresan Z, Muresan V (2008) Seeding neuritic plaques from the distance: a possible role for brainstem neurons in the development of Alzheimer’s disease pathology. Neurodegener Dis 5:250-253
329. Nave KA (2010) Myelination and support of axonal integrity by glia. Nature 468:244-252
330. Nelson PT, Jicha GA, Schmitt FA et al (2007) Clinicopathologic correlations in a large Alzheimer disease center autopsy cohort: neuritic plaques and neurofibrillary tangles “do count” when staging disease severity. J Neuropathol Exp Neurol 66:1136-1146
331. Nelson PT, Braak H, Markesbery WR (2009) Neuropathology and cognitive impairment in Alzheimer’s disease: a complex but coherent relationship. J Neuropathol Exp Neurol 68:1-14
332. Nelson PT, Head E, Schmitt FA et al (2011) Alzheimer’s disease is not “brain aging”: neuropathological, genetic, and epidemiologicical human studies. Acta Neuropathol 121:571-587
333. Niblock M, Gallo JM (2012) Tau alternative splicing in familial and sporadic tauopathies. Biochem Soc Trans 40:677-680
334. Nieuwenhuys R (1994) The neocortex. An overview of its evolutionary development, structural organization and synaptology. Anat Embryol 190:307-337
335. Nieuwenhuys R (1996) The greater limbic system, the emotional motor system and the brain. Prog Brain Res 107:551-580
336. Nieuwenhuys R (1999) Structure and organisation of fibre systems. In: Nieuwenhuys R, Ten Donkelaar JH, Nicholson C (eds) The central nervous system of vertebrates, vol 1. Springer, Berlin, pp 113-157
337. Nieuwenhuys R (2012) The insular cortex: a review. Prog Brain Res 195:123-163 O’Donnell J, Zeppenfeld D, McConnell E et al (2012) Norepinephrine: a neuromodulator that boosts the function of multiple cell types to optimize CNS performance. Neurochem Res 37:2496-2512
338. Ohm TG, Müller H, Braak H, Bohl J (1995) Close-meshed prevalence rates of different stages as a tool to uncover the rate of Alzheimer’s disease-related neurofibrillary changes. Neuroscience 64:209-217
339. Okamura N, Furumoto S, Harada R et al (2013) Novel 18F-labeled arylquinoline derivatives for noninvasive imaging of tau pathology in Alzheimer disease. J Nucl Med 54:1420-1427
340. Pamphlett R (2014) Uptake of environmental toxicants by the locus ceruleus. A potential trigger for enruodegenerative, demyelinating and psychiatric disorders. Med Hypotheses 82:97-104
341. Panula P, Airaksinen MS, Pirvola U, Kotilainen E (1990) A histamine-containing neuronal system in human brain. Neuroscience 34:127-132
342. Parvizi J, van Hoesen GW, Damasio A (1998) Severe pathological changes of parabrachial nucleus in Alzheimer’s disease. Neuroreport 9:4151-4154
343. Parvizi J, van Hoesen GW, Damasio A (2001) The selective vulnerability of brainstem nuclei to Alzheimer’s disease. Ann Neurol 49:53-66
344. Pearson RCA (1996) Cortical connections and the pathology of Alzheimer’s disease. Neurodegeneration 5:429-434
345. Pearson RCA, Powell TPS (1989) The neuroanatomy of Alzheimer’s disease. Rev Neurosci 2:101-122
346. Perani D (2014) FDG-PET and amyloid-PET imaging: the diverging paths. Curr Opin Neurol 27:405-413
347. Petersen RC (2000) Mild cognitive impairment: transition between aging and Alzheimer’s disease. Neurologia 15:93-101
348. Petersen RC (2009) Early diagnosis of Alzheimer’s disease: is MCI too late? Curr Alzheimer Res 6:324-330
349. Petersen RC (2011) Clinical practice. Mild cognitive impairment. N Engl J Med 364:2227-2234
350. Petersen RC, Doody R, Kurz A et al (2001) Current concepts in mild cognitive impairment. Arch Neurol 58:1985-1992
351. Petrides M, Pandya DN (2004) The frontal cortex. In: Paxinos G, Mai JK (eds) The human nervous system, 2nd edn. Elsevier, San Diego, CA, pp 951-974
352. Pikkarainen M, Martikainen P, Alafuzoff I (2010) The effect of prolonged fixation time on immunohistochemical staining of common neurodegenerative disease markers. J Neuropathol Appl Neurol 69:40-52
353. Pimplikar SW (2009) Reassessing the amyloid cascade hypothesis of Alzheimer’s disease. Int J Biochem Cell Biol 41:1261-1268
354. Pohanka M (2013) Alzheimer’s disease and oxidative stress: a review. Curr Med Chem 21:356-364
355. Price JL, Morris JC (1999) Tangles and plaques in nondemented aging and “preclinical” Alzheimer’s disease. Ann Neurol 45:358-368
356. Price JL, Morris JC (2004) So what if tangles precede plaques? Neurobiol Aging 25:721-723
357. Price JL, Davis PB, Morris JC, White DL (1991) The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer’s disease. Neurobiol Aging 12:295-312
358. Price JL, Carmichael ST, Drevets WC (1996) Networks related to the orbital and medial prefrontal cortex; a substrate for emotional behavior? Prog Brain Res 107:523-526
359. Prusiner S (2012) Cell biology. A unifying role for prions in neurodegenerative diseases. Science 336:1511-1515
360. Purohit DP, Batheja NO, Sano M et al (2011) Profiles of Alzheimer’s disease-related pathology in an aging urban population sample. J Alzheimer Dis 24:187-196
361. Purpura DP, Baker HJ (1978) Meganeurites and other aberrant processes of neurons in feline GM1-gangliosidosis: a Golgi study. Brain Res 143:13-26
362. Qiu C, Kivipelto M, von Strauss E (2009) Epidemiology of Alzheimer’s disease: occurrence, determinants, and strategies toward intervention. Dialogues Clin Neurosci 11:111-128
363. Raichle ME, Hartman BK, Eichling JO, Sharpe LG (1975) Central noradrenergic regulation of cerebral blood flow and vascular permeability. Proc Natl Acad Sci USA 72:3726-3730
364. Rajendran L, Annaert W (2012) Membrane trafficking pathways in Alzheimer’s disease. Traffic 13:759-770
365. Ramirez MJ, Lai MK, Tordera RM, Francis PT (2014) Serotonergic therapies for cognitive symptoms in Alzheimer’s disease: rationale and current status. Drugs 74:729-736
366. Ramon-Moliner E, Nauta WJH (1966) The isodendritic core of the brain stem. J Comp Neurol 126:311-336
367. Rapoport SI (1988) Brain evolution and Alzheimer’s disease. Rev Neurol (Paris) 144:79-90
368. Rapoport SI (1989) Hypothesis: Alzheimer’s disease is a phylogenetic disease. Med Hypotheses 29:147-150
369. Rapoport SI (1990) Integrated phylogeny of the primate brain, with special reference to humans and their diseases. Brain Res Rev 15:267-294
370. Rapoport SI (1999) How did the human brain evolve? A proposal based on new evidence from in vivo imaging during attention and ideation. Brain Res Bull 50:149-165
371. Rapoport SI, Nelson PT (2011) Biomarkers and evolution in Alzheimer’s disease. Prog Neurobiol 95:510-513
372. Reid AT, Evans AC (2013) Structural networks in Alzheimer’s disease. Eur Neuropsychopharmacol 23:63-77
373. Reinhard JF, Liebmann JE, Schlosberg AL, Moskowitz MA (1979) Serotonin neurons project to small blood vessels in the brain. Science 206:86-87
374. Reisberg B, Franssen EH, Hasan SM et al (1999) Retrogenesis: clinical, physiologic, and pathologic mechanisms in brain aging, Alzheimer’s and other dementing processes. Eur Arch Psychiatry Clin Neurosci 249(Suppl 3):28-36
375. Reisberg B, Franssen EH, Souren LE et al (2002) Evidence and mechanisms of retrogenesis in Alzheimer’s and other dementias: management and treatment import. Am J Alzheimers Dis Other Demen 17:202-212
376. Reitz C, Brayne C, Mayeux R (2011) Epidemiology of Alzheimer disease. Nat Rev Neurol 7:137-152
377. Rentz DM, Parra Rodriguez MA et al (2013) Promising developments in neuropsychological approaches for the detection of preclinical Alzheimer’s disease: a selective review. Alzheimers Res Ther 5:58
378. Revesz T, Holton JL, Lashley T et al (2009) Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies. Acta Neuropathol 118:115-130
379. Rockland KS, Pandya DN (1979) Laminar origins and terminations of cortical connections of the occipital lobe in the rhesus monkey. Brain Res 179:3-20
380. Rosa MI, Perucchi J, Medeiros LR et al (2014) Accuracy of cerebrospinal fluid Aβ(1-42) for Alzheimer’s disease diagnosis: a systematic review and meta-analysis. J Alzheimers Dis 40:443-454
381. Rosén C, Zetterberg H (2013) Cerebrospinal fluid biomarkers for pathological processes in Alzheimer’s disease. Curr Opin Psychiatry 26:276-282
382. Royall DR (2008) Insular Alzheimer disease pathology and the psychometric correlates of mortality. Cleve Clin J Med 75(Suppl 2):97-99
383. Royall DR, Gao JH, Kellogg DL (2008) Insular Alzheimer’s disease pathology as a cause of ‘agerelated’ autonomic dysfunction and mortality in the non-demented elderly. Med Hypotheses 67:747-758
384. Rüb U, Del Tredici K, Schultz C et al (2000) The evolution of Alzheimer’s disease-related cytoskeletal pathology in the human raphe nuclei. Neuropathol Appl Neurobiol 26:553-557
385. Rüb U, Del Tredici K, Schultz C et al (2001a) The premotor region essential for rapid vertical eye movements shows early involvement in Alzheimer’s disease-related cytoskeletal pathology. Vision Res 41:2149-2156
386. Rüb U, Del Tredici K, Schultz C et al (2001b) The autonomic higher oder processing nuclei of the lower brain stem are among the early targets of the Alzheimer’s disease-related cytoskeletal pathology. Acta Neuropathol 101:555-564
387. Rubial-Á lvarez S, de Sola S, Machado MC et al (2013) The comparison of cognitive and functional performance in children and Alzheimer’s disease supports the retrogenesis model. J Alzheimers Dis 33:193-203
388. Run X, Liang Z, Zhang L et al (2009) Anesthesia induces phosphorylation of tau. J Alzheimer Dis 16:619-629
389. Sabbagh MN, Cooper K, DeLange J et al (2010) Functional, global and cognitive decline correlates to accumulation of Alzheimer’s pathology in MCI and AD. Curr Alzheimer Res 7:280-286
390. Salloway S, Sperling R, Fox NC et al (2014) Two phase 3 trials of bapineuzumab in mild-tomoderate Alzheimer’s disease. N Engl J Med 370:322-333
391. Sämgård K, Zetterberg H, Blennow K et al (2010) Cerebrospinal fluid total tau as a marker of Alzheimer’s disease intensity. Int J Geriatr Psychiatry 25:403-410
392. Samuels ER, Szabadi E (2008) Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part I: principles of functional organization. Curr Neuropharmacol 6:235-253
393. Sanders DW, Kaufmann SW, DeVos SL et al (2014) Distinct tau prion strains propagate in cells and mice and define different tauopathies. Neuron 82:1271-1288
394. Saper CB (2004) Hypothalamus. In: Paxinos G, Mai JK (eds) The human nervous system, 2nd edn. Elsevier, San Diego, CA, pp 514-550
395. Saper CB, Weiner BH, German DC (1987) Axonal and transneuronal transport in the transmission of neurological disease: potential role in system degenerations, including Alzheimer’s disease. Neuroscience 23:389-398
396. Sara SJ (2009) The locus coeruleus and noradrenergic modulation of cognition. Nat Rev Neurosci 10:211-223
397. Sassin I, Schultz C, Thal DR et al (2000) Evolution of Alzheimer’s disease-related cytoskeletal changes in the basal nucleus of Meynert. Acta Neuropathol 100:259-269
398. Savica R, Petersen RC (2011) Prevention of dementia. Psychiatr Clin North Am 34:127-145
399. Schlaug G, Norton A, Overy K et al (2003) Effects of music training on the child’s brain and cognitive development. Ann NY Acad Sci 1060:219-230
400. Schliebs R, Arendt T (2011) The cholinergic system in aging and neuronal degeneration. Behav Brain Res 221:555-563
401. Scholz T, Mandelkow E (2014) Transport and diffusion of tau in neurons. Cell Mol Life Sci 71:3139-3150
402. Schönheit B, Zarski R, Ohm TG (2004) Spatial and temporal relationship between plaques and tangles in Alzheimer-pathology. Neurobiol Aging 25:697-711
403. Seitz DP, Reimer CL, Siddiqui N (2012) A review of epidemiological evidence for general anaesthesia as a risk factor for Alzheimer’s disease. Prog Neuropsychoüharmacol Biol Psychiatry 47:122-127
404. Selkoe DJ (1994) Alzheimer’s disease: a central role for amyloid. J Neuropathol Exp Neurol 53:438-447
405. Selkoe DJ (2000) Toward a comprehensive theory for Alzheimer’s disease: hypothesis: Alzheimer’s disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein. Ann NY Acad Sci 924:17-25
406. Selkoe D, Mandelkow E, Holtzman D (2012) Deciphering Alzheimer disease. Cold Spring Harb Perspect Med 2:1-8
407. Serrano-Pozo A, Frosch M, Masliah E, Hyman BT (2011) Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med 1:a006189
408. Serrano-Pozo A, Quian J, Monsell SE et al (2013) Examination of the clinicopathological continuum of Alzheimer disease in the autopsy cohort of the National Alzheimer Coordinating Center. J Neuropathol Exp Neurol 72:1182-1192
409. Shaw P, Kabani HJ, Lerch JP et al (2008) Neurodevelopmental trajectories of the human cerebral cortex. J Neurosci 28:3586-3594
410. Silverman W, Wisniewski HM, Bobinski M, Wegiel J (1997) Frequency of stages of Alzheimerrelated lesions in different age categories. Neurobiol Aging 18:377-379
411. Simic G, Bexheti S, Kelovic Z et al (2005) Hemispheric asymmetry, modular variability and age-related changes in the human entorhinal cortex. Neuroscience 130:911-925
412. Simic G, Stanic G, Mladinov M et al (2009) Does Alzheimer’s disease begin in the brainstem? Neuropathol Appl Neurobiol 35:532-554
413. Sinha UK, Hollen KM, Rodriguez R, Miller CA (1993) Auditory system degeneration in Alzheimer’s disease. Neurology 43:779-785
414. Smith GS, Kramer E, Ma Y et al (2009) Cholinergic modulation of the cerebral metabolic response to citaopram in Alzheimer’s disease. Brain 132:392-401
415. Sperling RA, Aisen PS, Beckett LA et al (2011) Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7:280-292
416. Spillantini MG, Goedert M (2013) Tau pathology and neurodegeneration. Lancet Neurol 12:609-622
417. Squire LR, Schacter DL (2002) Neuropsychology of memory. The Guilford, New York, NY Stephan H (1983) Evolutionary trends in limbic structures. Neurosci Biobehav Rev 7:367-374
418. Stern Y (2002) What is cognitive reserve? Theory and research application of the reserve concept. J Int Neuropsychol Soc 8:448-460
419. Stern Y (2009) Cognitive reserve. Neuropsychologia 47:2015-2028
420. Stokin GB, Goldstein LSB (2006) Axonal transport and Alzheimer’s disease. Ann Rev Biochem 75:607-627
421. Streit WJ, Braak H, Xue QS, Bechmann I (2009) Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer’s disease. Acta Neuropathol 118:475-485
422. Streit WJ, Xue QS, Braak H, Del Tredici K (2014) Presence of severe neuroinflammation does not intensify neurofibrillary degeneration in human brain. Glia 62:96-105
423. Stricker NH, Schweinsburg BC, Delano-Wood L et al (2009) Decreased white matter integrity in late-myelinating fiber pathways in Alzheimer’s disease supports retrogenesis. Neuroimage 45:10-16
424. Struble RG, Price DL Jr, Cork LC, Price DL (1985) Senile plaques in cortex of aged normal monkeys. Brain Res 361:267-275
425. Suzuki WA, Amaral DG (2004) Functional neuroanatomy of the medial temporal lobe memory system. Cortex 40:220-222
426. Szabadi E (2013) Functional neuroanatomy of the central noradrenergic system. J Psychopharmacol 27:659-693
427. Tago T, Furumoto S, Okamura N et al (2014) Synthesis and preliminary evaluation of 2-arylhydroxyquinoline derivatives for tau imaging. J Label Compd Radiopharm 57:18-24
428. Tapiola T, Alafuzoff I, Herukka SK et al (2009) Cerebrospinal fluid (beta)-amyloid 42 and tau proteins as biomarker changes in the brain. Arch Neurol 66:382-389
429. Tayab HO, Yang HD, Price BH, Tarazi FI (2012) Pharmacotherapies for Alzheimer’s disease: beyond cholinesterase inhibitors. Pharmacol Ther 134:8-25
430. Taylor KI, Probst A (2008) Anatomic localization of the transentorhinal region of the perirhinal cortex. Neurobiol Aging 29:1591-1596
431. Thal DR, Sassin I, Schultz C et al (1999) Fleecy amyloid deposits in the internal layers of the human entorhinal cortex are comprised of N-terminal truncated fragments of Abeta. J Neuropathol Exp Neurol 58:210-216
432. Thal DR, Rüb U, Orantes M, Braak H (2002) Phases of Aβ-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791-1800
433. Thal DR, Ghebremedhin E, Orantes M, Wiestler OD (2003) Vascular pathology in Alzheimer’s disease: correlation cerebral amyloid angiopathy and arteriosclerosis/lipohyalinosis with cognitive decline. J Neuropathol Exp Neurol 62:1287-1301
434. Thal DR, Grinberg LT, Attems J (2012) Vascular dementia: different forms of vessel disorders contribute to the development of dementia in the elderly brain. Exp Gerontol 47:816-824
435. Thal DR, von Arnim C, Griffin WS et al (2013) Pathology of clinical and preclinical Alzheimer’s disease. Eur Arch Psychiatry Clin Neurosci 263(Suppl 2):137-145
436. Thies E, Mandelkow EM (2007) Missorting of tau in neurons causes degeneration of synapses that can be rescued by the kinase MARK2/Par-1. J Neurosci 27:2896-2907
437. Tian H, Davidowitz E, Lopez P et al (2013) Trimeric tau is toxic to human neuronal cells at low nanomolar concentrations. Int J Cell Biol 2013, 260787
438. Tiraboschi P, Hansen LA, Thal LJ, Corey-Bloom J (2004) The importance of neuritic plaques and tangles to the development and evolution of AD. Neurology 62:1984-1989
439. Togo T, Akiyama H, Iseki E et al (2004) Immunohistochemical study of tau accumulation in early stages of Alzheimer-type neurofibrillary lesions. Acta Neuropathol 107:504-508
440. Toledo JB, Brettschneider J, Grossman M et al (2012) CSF biomarkers cutoffs: the importance of coincidental neuropathological diseases. Acta Neuropathol 124:23-35
441. Tolnay M, Probst A (1999) Review: tau protein pathology in Alzheimer’s disease and related disorders. Neuropathol Appl Neurobiol 25:171-187
442. Tomlinson BE, Irving D, Blessed G (1981) Cell loss in the locus coeruleus in senile dementia of Alzheimer type. J Neurol Sci 49:419-428
443. Toussay X, Basu K, Lacoste B, Hamel E (2013) Locus coeruleus stimulation recruits a broad cortical neuronal network and increases cortical perfusion. J Neurosci 33:3390-3401
444. Trillo L, Das D, Hsieh W et al (2013) Ascending monoaminergic systems alterations in Alzheimer’s disease, translating basic science into clinical care. Neurosci Biobehav Rev 37:1363-1379
445. Trojanowski JQ, Hampel H (2011) Neurogenerative disease biomarkers: guideposts for disease prevention through early diagnosis and intervention. Prog Neurobiol 95:491-495
446. Trojanowski JQ, Lee VMY (2000) “Fatal Attractions” of proteins: a comprehensive hypothetical mechanism underlying Alzheimer’s disease and other neurodegenerative disorders. Ann NY Acad Sci 924:62-67
447. Trojanowski JQ, Schuck T, Schmidt ML, Lee VM (1989) Distribution of tau proteins in the normal human central and peripheral nervous system. J Histochem Cytochem 37:209-215
448. Uchihara T, Nakamura A, Yamazaki M, Mori O (2001) Evolution from pretangle neurons to neurofibrillary tangles monitored by thiazin red combined with Gallyas method and double immunofluorescence. Acta Neuropathol 101:535-539
449. Uchihara T, Shibuya K, Nakamura A, Yagishita S (2005) Silver stains distinguish tau-positive structures in corticobasal degeneration/progressive supranuclear palsy and in Alzheimer’s disease-comparison between Gallyas and Campbell-Switzer methods. Acta Neuropathol 109:299-305
450. Uchihara T, Nakamura A, Shibuya K, Yagishita S (2011) Specific detection of pathological threerepeat tau after pretreatment with potassium permanganate and oxalic acid in PSP/CBD brains. Brain Pathol 21:180-188
451. Uchihara T, Hara M, Nakamura A, Hirokawa K (2012) Tangle evolution linked to differential 3-and 4-repeat tau isoform deposition: a double immunofluorolabeling study using two monoclonal antibodies. Histochem Cell Biol 137:261-267
452. Ullén F (2009) Is activity regulation of late myelination a plastic mechanism in the human nervous system? Neuron Glia Biol 5:29-34
453. Usher M, Cohen JD, Servan-Schreiber D et al (1999) The role of locus coeruleus in the regulation of cognitive performance. Science 283:549-554
454. Van Ba AT, Imberdis T, Perrier V (2013) From prion disease to prion-like propagation mechanisms of neurodegenerative diseases. Int J Cell Biol 2013, 975832
455. van der Knaap MS, Valk J, Bakker CJ et al (1991) Myelination as an expression of the functional maturity of the brain. Dev Med Child Neurol 33:849-857
456. van der Werf WMP, Groenewegen HJ (2002) The intralaminar and midline nuclei of the thalamus. Anatomical and functional evidence for participation in processes of arousal and awareness. Brain Res Rev 39:107-140
457. van Gool WA, Eikelenboom P (2000) The two faces of Alzheimer’s disease. J Neurol 247:500-505
458. van Hoesen GW, Hyman BT (1990) Hippocampal formation: anatomy and the patterns of pathology in Alzheimer’s disease. Prog Brain Res 83:445-457
459. Vana L, Kanaan NM, Ugwu IC et al (2011) Progression of tau pathology in cholinergic basal forebrain neurons in mild cognitive impairment and Alzheimer’s disease. Am J Pathol 179:2533-2550
460. Vanderstichele HM, Shaw L, Vandijck M et al (2013) Alzheimer disease biomarker testing in cerebrospinal fluid: a method to harmonize assay platforms in the absence of an absolute reference standard. Clin Chem 59:710-712
461. Velasco ME, Smith MA, Siedlak SI et al (1998) Striation is the characteristic neuritic abnormality in Alzheimer disease. Brain Res 813:329-333
462. Villemagne VL, Furumoto S, Fodero-Tavoletti MT et al (2014) In vivo evaluation of a novel tau imaging tracer for Alzheimer’s disease. Eur J Nucl Med Mol Imaging 41:816-826
463. Viswanathan A, Greenberg SM (2011) Cerebral amyloid angiopathy in the elderly. Ann Neurol 70:871-880
464. Vogt BA (2009) Regions and subregions of the cingulate cortex. In: Vogt BA (ed) Cingulate neurobiology and disease. Oxford University Press, New York, NY, pp 3-30
465. Vogt C, Vogt O (1919) Allgemeinere Ergebnisse unserer Hirnforschung. J Psychol Neurol 25:277-462
466. Vogt BA, Sikes RW, Vogt LJ (1993) Anterior cingulate cortex and the medial pain system. In: Vogt BA, Gabriel M (eds) Neurobiology of cingulate cortex and limbic thalamus. Birkhäuser, Boston, MA, pp 313-344
467. von Bergen M, Barghorn S, Biernat J et al (2005) Tau aggregation is driven by a transition from random coil to beta sheet structure. Biochim Biophys Acta 1739:158-166
468. Vonsattel JP, Myers RH, Hedley-Whyte ET et al (1991) Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study. Ann Neurol 30:637-649
469. Wagner J, Ryazanov S, Leonov A et al (2013) Anle138b: a novel oligomer modulator for diseasemodifying therapy of neurodegenerative diseases such as prion and Parkinson’s disease. Acta Neuropathol 125:795-813
470. Walker LC, Diamond MI, Duff KE, Hyman BT (2013) Mechanisms of protein seeding in neurodegenerative diseases. JAMA Neurol 70:304-310
471. Wang BW, Lu E, Mackenzie IR et al (2012) Multiple pathologies are common in Alzheimer patients in clinical trials. Can J Neurol Sci 39:592-599
472. Weaver CL, Espinoza M, Kress Y, Davies P (2000) Conformational change as one of the earliest alterations of tau in Alzheimer’s disease. Neurobiol Aging 21:719-727
473. Weinshenker D (2008) Functional consequences of locus coeruleus degeneration in Alzheimer’s disease. Curr Alzheimer Res 5:342-345
474. Weller RO, Massey A, Newman TA et al (1998) Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer’s disease. Am J Pathol 153:725-733
475. Weller RO, Biche D, Nicoll JA (2009) Microvasculature changes and cerebral amyloid angiopathy in Alzheimer’s disease and their potential impact on therapy. Acta Neuropathol 118:87-102
476. Whitehouse PJ, Price DL, Clark AW et al (1981) Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann Neurol 10:122-126
477. Whitehouse PJ, Struble RG, Hedreen JC et al (1985) Alzheimer’s disease and related dementias: selective involvement of specific neuronal systems. CRC Crit Rev Clin Neurobiol 1:319-339
478. Whittington RA, Bretteville A, Dickler MF, Planel E (2013) Anesthesia and tau pathology. Prog Neuro-Psychopharmacol Biol Psychiatry 47:147-155
479. Witter MP (1993) Organization of the hippocampal-entorhinal system: a review of current anatomical data. Hippocampus 3 Spec No:33-44
480. Woodruff AR, Anderson SA, Yuste R (2010) The enigmatic function of chandelier cells. Front Neurosci 4:201
481. Xu W, Yu JT, Tan MS, Tan L (2014) Cognitive reserve and Alzheimer’s disease. Mol Neurobiol. May 4 [Epub ahead of print]
482. Yamada M, Naiki H (2012) Cerebral amyloid angiopathy. Prog Mol Biol Transl Sci 107:41-78
483. Yan MH, Wang X, Zhu X (2013) Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease. Free Radic Biol Med 62:90-101
484. Yilmazer-Hanke DM (2012) Amygdala. In: Mai JK, Paxinos G (eds) The human nervous system, 3rd edn. Academic Press, San Diego, CA, pp 759-835
485. Yoshida M (2006) Cellular tau pathology and immunohistochemical study of tau isoforms in sporadic tauopathies. Neuropathology 26:457-470
486. Zaborszky I, Hoemke I, Mohlberg H et al (2008) Stereotaxic probabilistic maps of the magnoscellular cell groups in human basal forebrain. Neuroimage 42:1127-1141
487. Zakrzewska-Pniewska B, Gawel M, Szmidt-Salkowska E et al (2012) Clinical and functional assessment of dysautonomia and its correlation in Alzheimer’s disease. Am J Alzheimers Dis Other Demen 27:592-599
488. Zanelli O, Solerte SB, Cantoni F (2009) Life expectancy in Alzheimer’s disease (AD). Arch Gerontol Geriatr 49(Suppl 1):237-243
489. Zarow C, Lyness SA, Mortimer JA, Chui HC (2003) Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases. Arch Neurol 60:337-341
490. Zetterberg H, Pedersen M, Lind K et al (2007) Intra-individual stability of CSF biomarkers for Alzheimer’s disease over two years. J Alzheimers Dis 12:255-260
491. Zilles K, Amunts K (2010) Centenary of Brodmann’s map-conception and fate. Nat Rev Neurosci 11:139-145
492. Zweig RM, Ross CA, Hedreen JC (1988) The neuropathology of aminergic nuclei in Alzheimer’s disease. Ann Neurol 24:233-242